MRSN - Mersana Therapeutics, Inc.
29.08
0.040 0.138%
Share volume: 712,460
Last Updated: 01-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$29.04
0.04
0.00%
Summary score
22%
Profitability
25%
Dept financing
7%
Liquidity
50%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-37.6%
Return on assets
-11.32%
Return on sales
-8790.1%
Return on invested capital
121.07%
Total debt ratio
44.99%
Debt ratio change over timeo
0%
Current Ratio
4.59%
Quick Ratio
0%
Cash Position Ratio
3.19%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-18.21%
Return on assets
-13.48%
Return on sales
0%
Return on invested capital
342.53%
Total debt ratio
24.19%
Debt ratio change over timeo
0%
Current Ratio
6.77%
Quick Ratio
0%
Cash Position Ratio
5.38%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-7.23%
Return on assets
-6.37%
Return on sales
0%
Return on invested capital
290.54%
Total debt ratio
11.9%
Debt ratio change over time
0%
Current Ratio
13.15%
Quick Ratio
0%
Cash Position Ratio
12.86%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MRSN | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -37.6% | 17.45% | 4.69% | -3.05% |
| Return on assets | -11.32% | 3.37% | 3.35% | 3.6% |
| Return on sales | -8790.1% | 23.96% | 25.96% | 32.14% |
| Return on invested capital | 121.07% | 5.2% | 4.37% | 5.09% |
| Profitability | 25% | 68% | 51% | 51% |
| Total debt ratio | 44.99% | 77% | 57.66% | 101.18% |
| Debt ratio change over time | 0% | 0% | 10.55% | 69.81% |
| Dept financing | 11% | 19% | 18% | 50% |
| Current Ratio | 6.77% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 5.38% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 29% | 38% | 39% |
| Short-term ratios | MRSN | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -18.21% | 44.06% | 6.24% | -25.62% |
| Return on assets | -13.48% | 3.88% | 3.22% | 3.26% |
| Return on sales | 0% | 27.04% | 24.93% | 31.22% |
| Return on invested capital | 342.53% | 9.69% | 4.96% | 8.14% |
| Profitability | 25% | 72% | 45% | 47% |
| Total debt ratio | 24.19% | 91.8% | 61.39% | 105.33% |
| Debt ratio change over time | 0% | 0% | 12.93% | 15.97% |
| Dept financing | 6% | 22% | 35% | 50% |
| Current Ratio | 6.77% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 5.38% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 16% | 20% | 40% |